TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26254683

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery
Number of subjects: 366

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery (squamous cell carcinoma)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Surgery alone (squamous cell carcinoma)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery (adenocarcinoma)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Surgery alone (adenocarcinoma)
Number of subjects: 366
Study: 23497359

Group type: EXPERIMENTAL
Intervention: Feel the ViBe
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimally Enhanced Usual Care (mEUC)
Number of subjects: 0
Study: 21228267

Group type: COMPARATOR
Intervention: Control group (healthy children without CF)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Children with cystic fibrosis (CF)
Number of subjects: 34
Study: 19098076

Group type: EXPERIMENTAL
Intervention: Alcohol (white wine, men eight units, women six units)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Alcohol-free wine (control)
Number of subjects: 10
Study: 16492134

Group type: EXPERIMENTAL
Intervention: Cortisol (30 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 12736018

Group type: EXPERIMENTAL
Intervention: 22 mL of a 1% lidocaine solution injected into the neurovascular bundles, the genitourinary diaphragm, and between the rectal wall and prostate
Number of subjects: 50

Group type: COMPARATOR
Intervention: 10 mL of 2% intrarectal lidocaine jelly
Number of subjects: 50
Study: 11068978

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus routine care (RC)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Supportive counseling (SC) plus routine care (RC)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Routine care (RC) alone
Number of subjects: 87
Study: 8839196

Group type: EXPERIMENTAL
Intervention: Pamidronate 180 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pamidronate 100 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pamidronate (both dosages)
Number of subjects: 40
Study: 1451816

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antithrombin (AT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of low dose heparin and AT
Number of subjects: 0
Study: 6587753

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0
Study: 2874067

Group type: EXPERIMENTAL
Intervention: pindolol
Number of subjects: 32

Group type: COMPARATOR
Intervention: methyldopa
Number of subjects: 32
Study: 30636672

Group type: EXPERIMENTAL
Intervention: Leech therapy (4-7 leeches, single session)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Exercise therapy (4 weekly sessions, 1 hour each)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Leech therapy
Number of subjects: 44
Study: 28281865

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intervention group (PhD faculty)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (MD faculty)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 25699687

Group type: EXPERIMENTAL
Intervention: Peritoneal hypothermia before and for 3 hours after percutaneous coronary intervention
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Peritoneal hypothermia
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control
Number of subjects: 54
Study: 24329506

Group type: EXPERIMENTAL
Intervention: recombinant growth hormone (rhGH) treatment for 2 years
Number of subjects: 94
Study: 21124039

Group type: EXPERIMENTAL
Intervention: Weekly irinotecan-based therapy
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Biweekly irinotecan-based therapy
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: First-line therapy
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Second-line therapy
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Third-line therapy
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Patients <70 years old
Number of subjects: 601
Study: 18376682

Group type: COMPARATOR
Intervention: Isotonic saline irrigation
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Bupivacaine irrigation
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Lignocaine irrigation
Number of subjects: 200
Study: 16343039

Group type: EXPERIMENTAL
Intervention: Fenofibrate monotherapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fenofibrate + 10 mg folate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fluvastatin (80 mg)
Number of subjects: 18
Study: 12568856

Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO2)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 189
Study: 10904122

Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD) + Light Therapy (150 or 2500 lux)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Light Therapy
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Ongoing Lithium Treatment
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: TSD + Light Therapy
Number of subjects: 115
Study: 8997650

Group type: EXPERIMENTAL
Intervention: Guided Tissue Regeneration (GTR) with expanded polytetrafluoroethylene membrane
Number of subjects: 28

Group type: COMPARATOR
Intervention: Gingival Flap Surgery (GFS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Comparison of GTR vs GFS
Number of subjects: 28
Study: 1735865

Group type: EXPERIMENTAL
Intervention: Heparin surface modified intraocular lenses
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control intraocular lenses (PMMA without heparin)
Number of subjects: 266
Study: 6520804

Group type: EXPERIMENTAL
Intervention: Education and group discussion program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31205265

Group type: EXPERIMENTAL
Intervention: Exercise programme (thrice weekly, supervised exercise on a static bike for six weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (non-randomised cohort of LT patients receiving structured nutritional advice)
Number of subjects: 16
Study: 29564973

Group type: EXPERIMENTAL
Intervention: 20% 1RM (G20)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 40% 1RM (G40)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 60% 1RM (G60)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 80% 1RM (G80)
Number of subjects: 30

Group type: COMPARATOR
Intervention: All groups (G20, G40, G60, G80)
Number of subjects: 30
Study: 25900900

Group type: EXPERIMENTAL
Intervention: Parasternal block with pharmacologic analgesia (group P)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Pharmacologic analgesia alone (group C)
Number of subjects: 81
Study: 24450342

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 60
Study: 22985567

Group type: EXPERIMENTAL
Intervention: Super Lizer group (daily linearly polarized near-infrared irradiation)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: S+P group (daily Super Lizer and aerothermotherapy)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (drug therapy and shoulder exercise)
Number of subjects: 84
Study: 20496181

Group type: EXPERIMENTAL
Intervention: High-intensity functional weight-bearing exercise programme
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control activity
Number of subjects: 191
Study: 18353503

Group type: EXPERIMENTAL
Intervention: IV ondansetron (0.15 mg/kg; maximum 4 mg)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study: 15877944

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: External Beam Radiation Therapy (EBRT)
Number of subjects: 11
Study: 12206945

Group type: EXPERIMENTAL
Intervention: Dorsiflexion at 25 deg s(‐1)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dorsiflexion at 5 deg s(‐1)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dorsiflexion at both velocities
Number of subjects: 18
Study: 9696240

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 386

Group type: COMPARATOR
Intervention: No medication or other types of analgesics
Number of subjects: 386
Study: 8135395

Group type: EXPERIMENTAL
Intervention: Flexible, spiral‐wound tracheal tube (TT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard, preformed tracheal tube (TT)
Number of subjects: 40
Study: 2672485

Group type: EXPERIMENTAL
Intervention: Doxapram (variable rate infusion)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Mechanical ventilation
Number of subjects: 25
Study: 409101

Group type: EXPERIMENTAL
Intervention: TRH
Number of subjects: 15
Study: 30291545

Group type: COMPARATOR
Intervention: 0.4% fucoidan (D5)
Number of subjects: 6

Group type: COMPARATOR
Intervention: ≥0.2% fucoidan (D4, D5)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 0.2% fucoidan (D4)
Number of subjects: 6
Study: 30058979

Group type: EXPERIMENTAL
Intervention: PP1M->PP1M
Number of subjects: 4609

Group type: EXPERIMENTAL
Intervention: PP1M->PP3M
Number of subjects: 4609

Group type: COMPARATOR
Intervention: OA
Number of subjects: 4609
Study: 26860434

Group type: EXPERIMENTAL
Intervention: Internet-based walking program (Walkadoo) with a free wireless activity tracker, duration 6 weeks.
Number of subjects: 265

Group type: COMPARATOR
Intervention: No treatment (control group), duration 6 weeks.
Number of subjects: 265
Study: 24692480

Group type: EXPERIMENTAL
Intervention: Early goal‐directed fluid therapy (EGDT) guided by preload volume and cardiac output monitored by transpulmonary thermodilution
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard less‐invasive hemodynamic therapy guided by fluid balance or central venous pressure
Number of subjects: 160
Study: 23155313

Group type: EXPERIMENTAL
Intervention: Intraderal route (ID) with recombinant hepatitis B vaccine (Engerix B) 2 μg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intramuscular route (IM) with recombinant hepatitis B vaccine (Engerix B) 10 μg
Number of subjects: 58
Study: 19330600

Group type: EXPERIMENTAL
Intervention: Combination therapy with telmisartan 40 mg/day and hydrochlorothiazide (HCTZ) 12.5 mg/day (T + H, n = 32)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No change in current drug regimen (CTL, n = 32)
Number of subjects: 64
Study: 17890789

Group type: EXPERIMENTAL
Intervention: Mild diuretic treatment in addition to standard treatment for acute COPD exacerbation (group 1A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Standard treatment for acute COPD exacerbation (group 1B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stable COPD (group 2 control)
Number of subjects: 30
Study: 15538121

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11782726

Group type: EXPERIMENTAL
Intervention: Access to clinical information from a computer-based patient record system
Number of subjects: 2

Group type: COMPARATOR
Intervention: No access to clinical information from a computer-based patient record system
Number of subjects: 2
Study: 9025743

Group type: EXPERIMENTAL
Intervention: 117mSn(4+)DTPA at 180 microCi/kg (6.66 MBq/kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 117mSn(4+)DTPA at 229 microCi/kg (8.47 MBq/kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 117mSn(4+)DTPA at 285 microCi/kg (10.55 MBq/kg)
Number of subjects: 17
Study: 8200888

Group type: EXPERIMENTAL
Intervention: Electrical capacitive coupling treatment
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo unit
Number of subjects: 23
Study: 3310476

Group type: EXPERIMENTAL
Intervention: Autologous vein grafting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct suturing
Number of subjects: 0
Study: 28131433

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Attention control class
Number of subjects: 70
Study: 28395507

Group type: EXPERIMENTAL
Intervention: Pantoprazole (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ranitidine (n=20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 40
Study: 26627878

Group type: EXPERIMENTAL
Intervention: Elevated blood pressure (systolic ≥140 and/or diastolic ≥90 mm Hg) at any point during the trial
Number of subjects: 18201

Group type: EXPERIMENTAL
Intervention: Elevated blood pressure at any point during the trial
Number of subjects: 18201

Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 18201

Group type: EXPERIMENTAL
Intervention: Elevated blood pressure at study entry
Number of subjects: 18201
Study: 23642476

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed protein formula (eHPF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard preterm formula (SPF)
Number of subjects: 0
Study: 21903571

Group type: EXPERIMENTAL
Intervention: Primary wound closure
Number of subjects: 32

Group type: COMPARATOR
Intervention: Secondary wound closure
Number of subjects: 32
Study: 18362603

Group type: EXPERIMENTAL
Intervention: 4-day ambulatory continuous femoral nerve block with perineural ropivacaine 0.2%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 50
Study: 17138191

Group type: EXPERIMENTAL
Intervention: B-C-M (bupivacaine-clonidine-midazolam mixture)
Number of subjects: 110

Group type: COMPARATOR
Intervention: B-C (bupivacaine-clonidine mixture)
Number of subjects: 110
Study: 12683477

Group type: EXPERIMENTAL
Intervention: Abbreviated cognitive‐behavioral insomnia therapy (ACBT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sleep hygiene recommendations (SHC)
Number of subjects: 20
Study: 10919417

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.2% concentration
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sevoflurane at 1.5% concentration
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sevoflurane at 2% concentration
Number of subjects: 48

Group type: COMPARATOR
Intervention: Positive suggestion
Number of subjects: 48

Group type: COMPARATOR
Intervention: Neutral suggestion
Number of subjects: 48

Group type: COMPARATOR
Intervention: Bispectral index
Number of subjects: 48
Study: 8875723

Group type: EXPERIMENTAL
Intervention: 6-month chemotherapy (streptomycin, rifampicin, isoniazid)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 9-month chemotherapy (streptomycin, rifampicin, isoniazid)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 18-month chemotherapy (streptomycin, sodium para-aminosalicylic acid, isoniazid)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: All chemotherapy regimens (6-month, 9-month, 18-month)
Number of subjects: 114
Study: 7933184

Group type: COMPARATOR
Intervention: Maximal electrical sphincter stimulation (4 times 30 minutes)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Maximal electrical sphincter stimulation (30 minutes twice daily for 12 days)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Maximal electrical sphincter stimulation
Number of subjects: 13
Study: 2853406

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 46

Group type: COMPARATOR
Intervention: Diuretic and placebo (combined control group)
Number of subjects: 46
Study: 29609554

Group type: EXPERIMENTAL
Intervention: MyCourse - Moderate Drinking (intervention for alcohol moderation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MyCourse - Quit Smoking (intervention for smoking cessation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online static information brochure on alcohol (control for AM RCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online static information brochure on smoking (control for SC RCT)
Number of subjects: 0
Study: 28043937

Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg, once daily)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 407
Study: 25151552

Group type: EXPERIMENTAL
Intervention: Quiet Eye Training (QET)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional Technical Training (TT)
Number of subjects: 20
Study: 22130488

Group type: EXPERIMENTAL
Intervention: Enoxaparin followed by idrabiotaparinux (5-10 days' enoxaparin 1.0 mg/kg twice daily followed by subcutaneous idrabiotaparinux starting dose 3.0 mg)
Number of subjects: 3202

Group type: COMPARATOR
Intervention: Enoxaparin plus warfarin (adjusted-dose warfarin with target INR 2.0-3.0)
Number of subjects: 3202
Study: 19692375

Group type: EXPERIMENTAL
Intervention: Fixed-combination latanoprost/timolol
Number of subjects: 854

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 854

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 854
Study: 18478934

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with Shenqi-fuzheng injection
Number of subjects: 232

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 232
Study: 16335682

Group type: EXPERIMENTAL
Intervention: EP treatment with 2mg of estradiol (E2) for 5 years
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: EP treatment with 2mg of estradiol (E2) started before age 15
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: EP treatment with 2mg of estradiol (E2) started after age 20
Number of subjects: 72

Group type: COMPARATOR
Intervention: Patients with TS
Number of subjects: 72
Study: 12016345

Group type: EXPERIMENTAL
Intervention: Diffuse Muscle Coactivation (DMC) in persons with fibromyalgia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9685472

Group type: EXPERIMENTAL
Intervention: 15-minute videotape about polio vaccination and choices of schedules
Number of subjects: 287

Group type: COMPARATOR
Intervention: Vaccine Information Statement (VIS) only
Number of subjects: 287
Study: 8062601

Group type: EXPERIMENTAL
Intervention: 50/50 insulin mixture
Number of subjects: 18

Group type: COMPARATOR
Intervention: 70/30 insulin mixture
Number of subjects: 18
Study: 3055895

Group type: EXPERIMENTAL
Intervention: Gadolinium-DTPA-enhanced T1-weighted spin-echo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Unenhanced STIR scans
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: STIR sequences
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined approach using T1-weighted spin-echo, Gd-DTPA-enhanced T1-weighted spin-echo, and STIR images
Number of subjects: 20

Group type: COMPARATOR
Intervention: T2-weighted spin-echo images
Number of subjects: 20
Study: 30054099

Group type: EXPERIMENTAL
Intervention: Single-visit treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Chlorhexidine (CHX) group (2-visit treatment)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Calcium hydroxide group (2-visit treatment)
Number of subjects: 150
Study: 29146633

Group type: EXPERIMENTAL
Intervention: 10 days of antibiotics (including an option for complete outpatient therapy)
Number of subjects: 1552

Group type: COMPARATOR
Intervention: Appendectomy
Number of subjects: 1552

Group type: EXPERIMENTAL
Intervention: 10 days of antibiotics
Number of subjects: 1552
Study: 26396054

Group type: EXPERIMENTAL
Intervention: 40 g of daily walnut intake for 4 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: 5 g of daily walnut intake for 4 weeks
Number of subjects: 38
Study: 23237981

Group type: EXPERIMENTAL
Intervention: Four-wheeled walker
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: U-Step walker
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Two-wheeled walker
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Standard walker
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Laser light use on U-Step walker
Number of subjects: 27

Group type: COMPARATOR
Intervention: All devices except four-wheeled and U-Step walkers
Number of subjects: 27
Study: 22035826

Group type: EXPERIMENTAL
Intervention: High-intensity whole-body endurance-and-strength program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-intensity calisthenics-and-breathing-exercises program
Number of subjects: 40
Study: 18471953

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (US)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Laser therapy (Laser)
Number of subjects: 200
Study: 17071205

Group type: EXPERIMENTAL
Intervention: Oral calcium (3 g/d) and vitamin D (1 g/d) for 2 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: No supplement (control group)
Number of subjects: 90
Study: 15024770

Group type: EXPERIMENTAL
Intervention: Variwall nailing
Number of subjects: 44

Group type: COMPARATOR
Intervention: Kuntscher nailing
Number of subjects: 44
Study: 11095326

Group type: EXPERIMENTAL
Intervention: Alendronate 40 mg/day (N = 90)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Risedronate 30 mg/day (N = 89)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo (N = 36)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo with aspirin 650 mg q.i.d. for the last 7 days (N = 20)
Number of subjects: 235
Study: 9366932

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg bolus followed by 2 micrograms/kg/min infusion for 24 hours, then 1 microgram/kg/min for 48 hours)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1564126

Group type: EXPERIMENTAL
Intervention: Tenidap sodium 120 mg daily for 28 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tenidap sodium 120 mg daily
Number of subjects: 12
Study: 4073452

Group type: EXPERIMENTAL
Intervention: Amethocaine spinal anaesthesia (SAB)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Nitrous oxide‐halothane general anaesthesia (GA)
Number of subjects: 17
Study: 31702560

Group type: EXPERIMENTAL
Intervention: Web-based test for measuring refractive error
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Web-based test for uncorrected visual acuity
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Web-based test for corrected visual acuity
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Web-based test for participants with mild myopia (<3 D)
Number of subjects: 100